{"id":66748,"date":"2024-01-16T10:51:03","date_gmt":"2024-01-16T15:51:03","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=66748"},"modified":"2024-01-16T14:32:00","modified_gmt":"2024-01-16T19:32:00","slug":"metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/","title":{"rendered":"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation"},"content":{"rendered":"<p style=\"font-weight: 400\">A recent study analyzing data from four pivotal clinical trials\u2014LEADER, STEP 2, SUSTAIN 6, and PIONEER 6\u2014evaluated the impact of concomitant metformin use on gastrointestinal adverse events during the initiation and titration of glucagon-like peptide 1 receptor agonists (GLP-1RA).<\/p>\n<figure id=\"attachment_46277\" class=\"thumbnail wp-caption alignright\" style=\"width: 249px\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-46277\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-768x1024.jpg\" alt=\"klara-klein-endocrinology-fellow\" width=\"239\" height=\"317\" \/><figcaption class=\"caption wp-caption-text\">Klara Klein, MD, PhD<\/figcaption><\/figure>\n<p style=\"font-weight: 400\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/endocrinology-metabolism\/people\/klara-klein-md-phd\/\">Klara Klein, MD, PhD<\/a>, assistant professor of medicine in the UNC Division of Endocrinology led the 16,996-participant study, of which 76% were treated with metformin. Results showed no significant increase in the occurrence or severity of gastrointestinal adverse events among those using metformin during GLP-1RA initiation and titration. Additionally, concomitant metformin use did not contribute to an elevated risk of GLP-1RA discontinuation among participants who experienced gastrointestinal adverse events. Conversely, the analysis indicated that a higher percentage of metformin <em>nonusers<\/em> experienced gastrointestinal adverse events and subsequently discontinued the study product compared to metformin users.<\/p>\n<p style=\"font-weight: 400\">These findings provide reassurance to both healthcare providers and patients, suggesting incorporating metformin alongside GLP-1RA therapies does not intensify gastrointestinal symptoms or impact the overall tolerability of the treatment. Instead, increased counseling or slowed titration may be necessary in people who do not use metformin<em>.<\/em><\/p>\n<p style=\"font-weight: 400\">This <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048543\/\">multi-trial analysis, <\/a>published in Diabetes Care, the journal of the American Diabetes Association, underscores the safety and tolerability of combining metformin with GLP-1RA therapies during initiation and provides valuable insights for clinicians as they navigate personalized treatment plans for individuals with type 2 diabetes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A recent study analyzing data from four pivotal clinical trials\u2014LEADER, STEP 2, SUSTAIN 6, and PIONEER 6\u2014evaluated the impact of concomitant metformin use on gastrointestinal adverse events during the initiation and titration of glucagon-like peptide 1 receptor agonists (GLP-1RA). Klara Klein, MD, PhD, assistant professor of medicine in the UNC Division of Endocrinology led the &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\" aria-label=\"Read more about Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation\">Read more<\/a><\/p>\n","protected":false},"author":112673,"featured_media":46277,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[96,2,92,583],"tags":[673],"class_list":["post-66748","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-endocrinology-metabolism","category-news","category-research","category-research-news","tag-673","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"A recent study analyzing data from four pivotal clinical trials\u2014LEADER, STEP 2, SUSTAIN 6, and PIONEER 6\u2014evaluated the impact of concomitant metformin use on gastrointestinal adverse events during the initiation and titration of glucagon-like peptide 1 receptor agonists (GLP-1RA). Klara Klein, MD, PhD, assistant professor of medicine in the UNC Division of Endocrinology led the &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-16T15:51:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-16T19:32:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Morgan Duerden\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Morgan Duerden\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\"},\"author\":{\"name\":\"Morgan Duerden\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9\"},\"headline\":\"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation\",\"datePublished\":\"2024-01-16T15:51:03+00:00\",\"dateModified\":\"2024-01-16T19:32:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\"},\"wordCount\":248,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg\",\"keywords\":[\"2024\"],\"articleSection\":[\"Endocrinology and Metabolism\",\"News\",\"Research\",\"Research News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\",\"name\":\"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg\",\"datePublished\":\"2024-01-16T15:51:03+00:00\",\"dateModified\":\"2024-01-16T19:32:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg\",\"width\":1920,\"height\":2560,\"caption\":\"Klara Klein, MD, PhD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9\",\"name\":\"Morgan Duerden\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g\",\"caption\":\"Morgan Duerden\"},\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/duerdenm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/","og_locale":"en_US","og_type":"article","og_title":"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation | Department of Medicine","og_description":"A recent study analyzing data from four pivotal clinical trials\u2014LEADER, STEP 2, SUSTAIN 6, and PIONEER 6\u2014evaluated the impact of concomitant metformin use on gastrointestinal adverse events during the initiation and titration of glucagon-like peptide 1 receptor agonists (GLP-1RA). Klara Klein, MD, PhD, assistant professor of medicine in the UNC Division of Endocrinology led the &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2024-01-16T15:51:03+00:00","article_modified_time":"2024-01-16T19:32:00+00:00","og_image":[{"width":1920,"height":2560,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg","type":"image\/jpeg"}],"author":"Morgan Duerden","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Morgan Duerden","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/"},"author":{"name":"Morgan Duerden","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9"},"headline":"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation","datePublished":"2024-01-16T15:51:03+00:00","dateModified":"2024-01-16T19:32:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/"},"wordCount":248,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg","keywords":["2024"],"articleSection":["Endocrinology and Metabolism","News","Research","Research News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/","name":"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg","datePublished":"2024-01-16T15:51:03+00:00","dateModified":"2024-01-16T19:32:00+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg","width":1920,"height":2560,"caption":"Klara Klein, MD, PhD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/metformin-use-shows-no-increase-in-gastrointestinal-adverse-events-during-glp-1ra-initiation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9","name":"Morgan Duerden","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g","caption":"Morgan Duerden"},"url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/duerdenm\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-scaled.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-225x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-768x1024.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-768x1024.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/09\/klara-klein-150x150.jpg","featured_image_alt":"klara-klein-endocrinology-fellow","category_details":[{"name":"Endocrinology and Metabolism","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/endocrinology-metabolism\/"},{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"},{"name":"Research","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/research\/"},{"name":"Research News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/research-news\/"}],"tag_details":[{"name":"2024","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2024\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/66748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/112673"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=66748"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/66748\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/46277"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=66748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=66748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=66748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}